Activation of CMKLR1 by chemerin has well‐established roles in inflammation, adipogenesis, and insulin sensitivity, and thus chemerin has a firm role in the pathology of obesity and metabolic syndrome.1 There is increasing recognition of the association between metabolic syndrome and cardiovascular disease. Here, CMKLR1 is linked to cardiovascular disorder.